NFL Biosciences SAS (ALNFL) — Strategic Asset Allocation Index
NFL Biosciences SAS (ALNFL) has a Strategic Asset Allocation Index of 0.1% as of June 2022. Strategic assets (PP&E of €2.63K plus long-term investments of €-) total €2.63K, measured against net assets of €2.22 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of NFL Biosciences SAS to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
NFL Biosciences SAS Strategic Asset Allocation Index (2019–2021)
This chart shows how NFL Biosciences SAS's Strategic Asset Allocation Index has evolved across 3 annual periods from 2019 to 2021. As of June 2022, the index stands at 0.1%, representing strategic assets of €2.63K against net assets of €2.22 Million EUR. For live market cap and overall valuation, see NFL Biosciences SAS (ALNFL) market capitalisation.
Annual Strategic Asset Allocation Index for NFL Biosciences SAS (2019–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for NFL Biosciences SAS from 2019 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See ALNFL net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.1% | €1.99K | €1.99K | €- | €3.29 Million | ▲ +0.1 pp |
| 2020 | 0.0% | €0.00 | €0.00 | €- | €150.03K | ▼ 0.0 pp |
| 2019 | 0.0% | €30.00 | €30.00 | €- | €411.52K | — |